この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1994/6/231 分で読めます
Clay-Park Labs, Inc.; Withdrawal of Approval of Three Abbreviated Applications
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is withdrawing approval of one abbreviated antibiotic drug application (AADA) and two abbreviated new drug applications (ANDA's) held by Clay-Park Labs, Inc., 1700 Bathgate Ave., Bathgate Industrial Park, Bronx, NY 10457 (Clay-Park). FDA is withdrawing approval of these applications because of questions raised about the reliability of the data and information submitted to FDA in support of the applications. Clay-Park requested this withdrawal and in so doing has waived its opportunity for a hearing.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →